Tracking Medicare news, policy, and coverage changes.
(MedPage Today) -- Note that some links may require registration or subscription. Three lots of American Regent epinephrine injection USP 30 mg/ 30 mL were recalled nationwide due to a lack of sterility assurance and the presence of particulate...
Read full article →The contract lapse comes as the health system and cancer institute are winding down a decades-old partnership.
Read full article →The platform is currently available in 41 states and Washington, D.C., with plans to expand nationally by the end of 2026.
Read full article →Parakeet Health landed a major partnership with Qualderm, one of the nation's largest dermatology organizations, as the company looks to apply agentic artificial intelligence to a growing specialty care access problem.
Read full article →GenHealth.ai’s agents automate revenue cycle workflows end-to-end across EHRs, payer portals and more.
Read full article →An itchy skin fungus that resists standard treatment has spread to 29 countries, and cases have tripled in just a few years.
Read full article →Kids with obesity-related conditions like high cholesterol or sleep apnea were substantially more likely to be prescribed GLP-1s than those without.
Read full article →The nation’s uninsured rate hit a historical low when Xavier Becerra was health secretary. Now he wants to be California’s next governor as states stare down the biggest rise in the uninsured rate in a generation.
Read full article →The true cost of “vertical integration”: patients directed to a higher-priced location for procedures. Or forced to buy from their insurer’s wholly owned pharmacy, which may not stock the drug prescribed or provide it at the lowest price.
Read full article →These positive results could open up a new way to treat serious lung disease.
Read full article →The decision to move ahead with new products in the absence of FDA authorization could spur other big manufacturers to do the same, one tobacco-nicotine expert said.
Read full article →When the FDA approved a new pancreatic cancer drug called Rasonque, researchers celebrated. But some patients hoping for quick access have been stymied.
Read full article →